Posted on 13/12/05
Lorus reports positive results in drug trial
Drug developer Lorus Therapeutics Inc. has reported positive interim clinical results with an experimental treatment for a form of leukemia.In a presentation to the American Society of Hematology meeting in Atlanta yesterday, Toronto-based Lorus said its GTI-2040 drug combined with the chemotherapy drug cytarabine eliminated acute myeloid leukemia (AML) in 44 per cent of patients aged 60 or younger.
The full text of this article has 206 words.
To continue reading this article, you will need to purchase this article.
Already have a member account? Login now
Pay-Per-View Offers To read the complete article, select one of the following options
Purchasing from globeandmail.com is quick and secure.
